✦ LIBER ✦

Considerations in Developing a Target Product Profile for Parenteral Pharmaceutical Products

✍ Scribed by William J. Lambert

Book ID: 111768259
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 107 KB
Volume: 11
Category: Article
ISSN: 1530-9932
DOI: 10.1208/s12249-010-9521-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmaceutical Emulsions (A Drug Develop

Pharmaceutical Emulsions (A Drug Developer's Toolbag) || Product Considerations: Medicinal Formulations

✍ Sarker, Dipak K. 📂 Article 📅 2013 🏛 John Wiley & Sons, Ltd ⚖ 470 KB

Practical considerations for pharmaceuti

Practical considerations for pharmaceutical antibody production in different crop systems

✍ Eva Stoger; Markus Sack; Yolande Perrin; Carmen Vaquero; Esperanza Torres; Richa 📂 Article 📅 2002 🏛 Springer Netherlands 🌐 English ⚖ 186 KB

Co-production: A viable consideration fo

Co-production: A viable consideration for developing nations

✍ Olga Quintana 📂 Article 📅 1984 🏛 Sage Publications 🌐 English ⚖ 504 KB

Prioritizing multipurpose prevention tec

Prioritizing multipurpose prevention technology development and investments using a target product profile

✍ Romano, Joe; Manning, Judy; Hemmerling, Anke; McGrory, Elizabeth; Young Holt, Be 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 440 KB

Development of a Pharmaceutical Apotrans

Development of a Pharmaceutical Apotransferrin Product for Iron Binding Therapy

✍ Leni von Bonsdorff; Hannele Tölö; Enni Lindeberg; Tuula Nyman; Anna Harju; Jaakk 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Mass spectrometry for small molecule pha

Mass spectrometry for small molecule pharmaceutical product development: A review

✍ Todd A. Gillespie; Brian E. Winger 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

## Abstract Developing a pharmaceutical product has become increasingly difficult and expensive. With an emphasis on developing project knowledge at an earlier stage in development, the use of information‐rich technologies (particularly MS) has continued to expand throughout product development. Co